
Zionexa USA and PETNET Solutions announce FDA approval of Cerianna (Fluoroestradiol F 18)
DENOS is pleased to announce that its biotech affiliate Zionexa, specialized in the development and commercialization of innovative biomarkers for diagnosis and targeted therapies in